<p>In the end I manage to do 2 cohorts
1: Long Covid Patients (1300N)
2: NON Long Covid Patients that had Covid (1300).</p>
<p>It was the most rational thing to do, and professor liked it. So that's how I manage in th end.</p>

CC BY-SA 4.0
2021-10-19T15:31:27.360Z
2021-10-19T15:31:27.360Z
fecke9296
<p>I am working on a project proposal for an exam, it involves a budget of 1M euros and I got to design a genomic study. I chose a GWAS to assess altered gene expression after covid19 that leads to long-COVID. I thought about 3 cohorts:</p>
<p>Case cohort1: Long-Covid patients (N: 3,000)</p>
<p>Case cohort2: Fully recovered patients (N: 3000)</p>
<p>Control cohort: healthy patients. (N: 6000)</p>
<p>Would it make sense to run two GWAS for the two case cohorts against the control cohort (cohort1/controls and cohort2/controls) then do a miami plot to see if there are some hits that differs from the two cohorts, and pick the ones only presented in the Long-covid for further assessment?</p>
<p>The study will also be supported by a validation step for both gwas. What do you think about this idea? Would it make sense or the fully-recovered patients against control cohorts is totally useless? Thank you in advance</p>

<covid-19><gwas>
Long-Covid (LC) GWAS project proposal: should I include a non-LC GWAS?
# Long-Covid (LC) GWAS project proposal: should I include a non-LC GWAS?

(Asked by: username_0 on 2021-07-04)

I am working on a project proposal for an exam, it involves a budget of 1M euros and I got to design a genomic study. I chose a GWAS to assess altered gene expression after covid19 that leads to long-COVID. I thought about 3 cohorts:

Case cohort1: Long-Covid patients (N: 3,000)

Case cohort2: Fully recovered patients (N: 3000)

Control cohort: healthy patients. (N: 6000)

Would it make sense to run two GWAS for the two case cohorts against the control cohort (cohort1/controls and cohort2/controls) then do a miami plot to see if there are some hits that differs from the two cohorts, and pick the ones only presented in the Long-covid for further assessment?

The study will also be supported by a validation step for both gwas. What do you think about this idea? Would it make sense or the fully-recovered patients against control cohorts is totally useless? Thank you in advance

**Tags:** covid-19, gwas

---

## 1 answers

### Answer by username_0 on 2021-10-19. Score: 2 | Accepted answer

In the end I manage to do 2 cohorts
1: Long Covid Patients (1300N)
2: NON Long Covid Patients that had Covid (1300).

It was the most rational thing to do, and professor liked it. So that's how I manage in th end.


---

